GlassScriptPhysician profile
Lindsay Head
NPI 1982350351
$8,425.69
in general payments reported to CMS, 2019-2025
13 companies · $5,168 in 2025
The $5,168 reported for 2025 was more than what 99% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $281 · 2023: $121 · 2024: $2,855 · 2025: $5,168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,906 · Travel and Lodging: $2,238 · Consulting Fee: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,906.15 |
| Travel and Lodging | $2,238.16 |
| Consulting Fee | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $5,847.54 | 2024-2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Medtronic, INC. | $1,578.70 | 2022-2025 | Penditure, Avalus, Mc3 Nautilus(Tm) Ecmo Oxygenator |
| Bolton Medical INC | $321.83 | 2024-2025 | Thoraflex Hybrid, Treo Abdominal Stent-Graft System |
| Edwards Lifesciences Corporation | $194.40 | 2025 | |
| Amgen INC. | $170.13 | 2024-2025 | Repatha, Repatha |
| Abiomed | $147.69 | 2022-2024 | Impella |
| Zimmer Biomet Holdings, INC. | $57.44 | 2025 | A&E Medical / Sternalock Xp Rigid Fixation System |
| Astrazeneca Pharmaceuticals LP | $23.58 | 2025 | Wainua |
| Teleflex LLC | $18.63 | 2024 | Manta |
| E.R. Squibb & Sons, L.L.C. | $17.28 | 2024 | Eliquis |
| La Jolla Pharmaceutical Company | $17.00 | 2023 | Giapreza |
| Novo Nordisk INC | $16.77 | 2024 | Rybelsus, Ozempic |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.70 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsay Head listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.